UK markets closed

Theralase Technologies Inc. (TLT.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.1650+0.0050 (+3.13%)
At close: 03:59PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 38.29M
Enterprise value 38.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)32.88
Price/book (mrq)20.09
Enterprise value/revenue 36.09
Enterprise value/EBITDA -9.08

Trading information

Stock price history

Beta (5Y monthly) 1.59
52-week change 3-33.33%
S&P500 52-week change 322.38%
52-week high 30.3100
52-week low 30.1500
50-day moving average 30.1854
200-day moving average 30.2084

Share statistics

Avg vol (3-month) 3126.04k
Avg vol (10-day) 370.6k
Shares outstanding 5239.3M
Implied shares outstanding 6239.3M
Float 8218.45M
% held by insiders 18.14%
% held by institutions 10.00%
Shares short (15 Apr 2024) 466.02k
Short ratio (15 Apr 2024) 40.32
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.03%
Shares short (prior month 15 Mar 2024) 479.68k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-275.26%

Management effectiveness

Return on assets (ttm)-77.21%
Return on equity (ttm)-182.91%

Income statement

Revenue (ttm)1.07M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)N/A
EBITDA -4.4M
Net income avi to common (ttm)-4.57M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.91k
Total cash per share (mrq)0
Total debt (mrq)386.88k
Total debt/equity (mrq)20.30%
Current ratio (mrq)1.39
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-4.07M
Levered free cash flow (ttm)-2.09M